Losartan Potassium 50 mg Tablet — Class II drug recall D-0788-2022
Terminated recall by RemedyRepack Inc., reported 2022-05-04, distributed in AK, PA. CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.
| Recall number | D-0788-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | RemedyRepack Inc., Indiana, PA, United States |
| Recall initiated | 2022-04-06 |
| Classified | 2022-04-26 |
| Reported by FDA | 2022-05-04 |
| Terminated | 2022-05-27 |
| Distributed | AK, PA |
| Reason classes | cgmp, specification failure |
| NDC | 70518-3282-00, 70518-3282-01 |
| Lot numbers | B1467803-120621, J0585793-121721 |
| Expiration dates | 2022-06-30, 2022-12-31 |
Product
Losartan Potassium 50 mg Tablet, a) 30-count blister card (NDC# 70518-3282-1), b) 60-count blister card (NDC: 70518-3282-0), Rx Only, MFG by: Lupin Pharma, Baltimore, MD 21202.
Reason for recall
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0788-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.